Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)
First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)
Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
Peter Young – Chemical Heritage Foundation Bolte Award (2017)
Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
In M&A, Now You See It, Now You Don’t – Young & Partners ICIS Chemical Business Feb 24, 2017 issue)
Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.
Chemical Financing Hits Record Levels – Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)
Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
Pharma and Biotech Markets – Challenges and Opportunities (Pharma Exec January 2017 Issue)
Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management
A Fireside Chat with Dr. Stephen Miller (Pharmaceutical Executive Magazine Nov 30, 2016)
Peter Young interviews Dr. Stephen Miller of Express Scripts about his career and industry thoughts
Chemical Week – M&A Moderates Despite Announced Mega Deals (November 28, 2016)
Editor-in-Chief interviews Young & Partners about M&A market slowdown and shift to Asia
Capital Markets Shift Amid Volatility (ICIS Chemical Business November 21, 2016 issue)
Young & Partners dissects the volatile debt and equity markets, including the Western IPO drought
Creating Value in a Challenging Market (ICIS Chemical Business November 14 – 20, 2016 issue)
Young & Partners article documents the slower and shifting M&A market - contrary to conventional Wisdom